|
TP2207 |
Pasireotide Acetate
|
|
Somatostatin
|
|
Pasireotide Acetate is a stable cyclohexapeptide somatostatin mimic |
|
T0081 |
Lafutidine
|
FRG-8813 |
5-HT Receptor
,
Histamine Receptor
|
|
Lafutidine (FRG-8813) is a newly developed histamine H(2)-receptor antagonist, which can inhibit gastric acid secretion. |
|
T8388 |
Vonoprazan
|
TAK-438 (free base) |
Proton pump
|
|
Vonoprazan (TAK-438 (free base)) is an orally active potassium-competitive acid blocker.Vonoprazan can be used for the treatment of gastroduodenal ulcer and reflux esophagitis |
|
T21254 |
Vonoprazan Fumarate
|
TAK-438,TAK 438,Vonoprazan Fumurate,TAK438 |
Proton pump
|
|
Vonoprazan Fumarate (TAK438) , a novel potassium-competitive acid blocker, inhibits gastric acid secretion. Vonoprazan Fumarate (TAK438) inhibited H+,K+-ATPase activity in porcine gastric microsomes with IC50 value of 19... |
|
T29015 |
Trithiozine
|
Tresanil,Sulmetozine,Tritiozinum,Tritiozine,Tritiozina |
Others
|
|
Trithiozine (Tritiozinum) exhibits antisecretory and antiulcer capacity. Trithiozine can be used for research on the treatment of peptic ulcer disease and hypersecretory disorders. |
|
T15195 |
Ebrotidine
|
FI3542 |
Histamine Receptor
|
|
Ebrotidine (FI3542) is a competitive H2-receptor antagonist with Ki of 127.5 nM. Ebrotidine has a potent antisecretory activity and evidenced gastroprotection. |
|
T6710 |
Troxipide
|
Aplace |
Others
|
|
Troxipide (Aplace), a new-type systemic non-antisecretory gastric cytoprotective agent, which is mucus-secreting, anti-ulcer, and anti-inflammatory properties irrespective of pH of stomach or duodenum. |
|
T2138 |
Oxyphencyclimine Hydrochloride
|
Spazamin,Daricon,Ulcociclinina |
AChR
|
|
Oxyphencyclimine Hydrochloride (Ulcociclinina) is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities. |
|
T0786 |
Clidinium bromide
|
Ro 2-3773 |
AChR
|
|
Clidinium bromide (Ro 2-3773) , a synthetic anticholinergic agent, has been shown in experimental and clinical researchers to have a pronounced antisecretory and antispasmodic effect on the gastrointestinal tract. It can... |
|
T31195 |
Dalcotidine
|
KU 1257,KU-1257 |
Histamine Receptor
|
|
Dalcotidine (KU 1257) is a novel histamine H2 receptor antagonist with histamine H9 receptor antagonistic activity and antisecretory effects.The Ki value for binding to guinea pig cerebral cortex was 0.040 The KB value f... |
|
T13382 |
Zaltidine
|
CP-57361 |
Others
|
|
Zaltidine is an antagonist of H2-receptor, and has the antisecretory action. |
|
TP2343 |
Lagatide
|
|
|
|
Lagatide is a synthetic heptapeptide that has antisecretory activity. |
|
T71390 |
AY 29315
|
|
|
|
AY 29315 is a histamine H2-receptor antagonist with antisecretory and antiulcer activities. |
|
T12369 |
Pasireotide pamoate
|
SOM230 pamoate |
Others
|
|
Pasireotide pamoate is a stable cyclohexapeptide somatostatin mimic. Pasireotide pamoate exhibits antisecretory, antiproliferative, and proapoptotic activity. |
|
T68133 |
Quisultazine
|
|
|
|
Quisultazine is a phenothiazine derivative with no central effects, can be classified as a non anti H2 antisecretory agent. |
|
T70473 |
Parapenzolate Free Base
|
|
|
|
Parapenzolate Free Base is a safe and effective anticholinergic drug possessing antisecretory and antimotility properties and prolonged duration of action. Clinical investigation has shown that after an oral dose of the ... |
|
T36154 |
15(S)-15-methyl Prostaglandin E2
|
15(S)-15-methyl Prostaglandin E2 |
|
|
15(S)-15-methyl PGE2 is a potent, metabolically stable analog of PGE2. It is a potent gastric antisecretory and antiulcer compound. 15(S)-15-methyl PGE2 binds to human myometrium with twice the affinity of PGE2 and is te... |
|
T27092 |
CS-526
|
R-105266,R 105266,R105266 |
|
|
CS-526 is a proton pump inhibitor. The inhibitory mechanism of CS-526 on H+,K+-ATPase was a competitive antagonism to the K+ binding site of H+,K+-ATPase, and it was also a reversible inhibition. CS-526 has a potent anti... |
|
T9660 |
Bexlosteride
|
|
|
|
Bexlosteride (LY300502), a benzoquinolinone derivative, functions as a human type I 5α-reductase inhibitor. It demonstrates metabolic inhibition, antiproliferative, and antisecretory activities specifically in LNCaP huma... |
|
T75248 |
Pasireotide (diaspartate)
|
|
|
|
Pasireotide diaspartate (SOM230), a long-acting cyclohexapeptide and somatostatin analog, enhances agonist activity across somatostatin receptor subtypes (sst1/2/3/4/5, with pK i values of 8.2, 9.0, 9.1, <7.0, and 9.9, r... |
|
TMIH-0163 |
Clidinium Bromide-d5
|
|
|
|
Clidinium Bromide-d5 is a deuterated compound of Clidinium Bromide. Clidinium Bromide has a CAS number of 3485-62-9. Clidinium, a synthetic anticholinergic agent, has been shown in experimental and clinical researchers t... |
|
T28331 |
PD 136450
|
Cam1189,PD136450,Cam-1189,PD-136450,Cam 1189 |
|
|
Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. Gastrin (cholecystokinin type B (CCK-B)) receptor antagonists may help to... |
|
T61643 |
Vonoprazan hydrochloride
|
|
|
|
Vonoprazan hydrochloride, a proton pump inhibitor (PPI), effectively acts as a potassium-competitive acid blocker (P-CAB) with potent antisecretory activity. It notably inhibits H+,K+-ATPase activity in porcine gastric m... |
